(Q46452051)

22 December 2017

title

"Superbugs bunny" outsmarts our immune defense (English)

1 reference

22 December 2017

author name string

Dieter Haebich

series ordinal

1

1 reference

22 December 2017

Franz von Nussbaum

series ordinal

2

1 reference

22 December 2017

publication date

1 August 2008

1 reference

22 December 2017

published in

ChemMedChem

1 reference

22 December 2017

volume

3

1 reference

22 December 2017

issue

8

1 reference

22 December 2017

page(s)

1173-1177

1 reference

22 December 2017

Carotenoid radical chemistry and antioxidant/pro-oxidant properties.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800171

7 January 2021

MRSA: status and prospects for therapy? An evaluation of key papers on the topic of MRSA and antibiotic resistance

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800171

7 January 2021

Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800171

7 January 2021

Invasive methicillin-resistant Staphylococcus aureus infections in the United States

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800171

7 January 2021

Molecular mechanisms that confer antibacterial drug resistance

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800171

7 January 2021

Mechanisms of resistance to antibiotics

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800171

7 January 2021

Molecular mechanisms of antibacterial multidrug resistance

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800171

7 January 2021

'Superbug' hurdles key drug barrier

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800171

7 January 2021

Epidemic community-associated methicillin-resistant Staphylococcus aureus: recent clonal expansion and diversification.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800171

7 January 2021

Late stage antibacterial drugs in the clinical pipeline

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800171

7 January 2021

Natural products to drugs: daptomycin and related lipopeptide antibiotics

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800171

7 January 2021

Chemistry and biology of ramoplanin: a lipoglycodepsipeptide with potent antibiotic activity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800171

7 January 2021

Platensimycin, a new antibiotic and "superbug challenger" from nature

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800171

7 January 2021

Medicinal chemistry optimization of acyldepsipeptides of the enopeptin class antibiotics.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800171

7 January 2021

Total syntheses of lysobactin (katanosin B)

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800171

7 January 2021

Structure and total synthesis of lysobactin (katanosin B)

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800171

7 January 2021

Total synthesis and initial structure-activity relationships of longicatenamycin A.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800171

7 January 2021

(Genome) size matters

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800171

7 January 2021

Whither antibacterial drug discovery?

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800171

7 January 2021

Where will new antibiotics come from?

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800171

7 January 2021

Antibakterielle Naturstoffe in der medizinischen Chemie – Exodus oder Renaissance?

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800171

7 January 2021

Antibacterial natural products in medicinal chemistry--exodus or revival?

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800171

7 January 2021

Surviving the blockbuster syndrome

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800171

7 January 2021

A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800171

7 January 2021

Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800171

7 January 2021

How neutrophils kill microbes

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800171

7 January 2021

Antimicrobial reactive oxygen and nitrogen species: concepts and controversies

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800171

7 January 2021

The Haber-Weiss reaction and mechanisms of toxicity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800171

7 January 2021

Neutrophil-mediated oxidative burst and host defense are controlled by a Vav-PLCgamma2 signaling axis in mice

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800171

7 January 2021

Staphyloxanthin plays a role in the fitness of Staphylococcus aureus and its ability to cope with oxidative stress

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800171

7 January 2021

Structure and biosynthesis of staphyloxanthin from Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800171

7 January 2021

Genetic and biochemical analyses of the biosynthesis of the yellow carotenoid 4,4'-diaponeurosporene of Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800171

7 January 2021

Pigments of Staphylococcus aureus, a series of triterpenoid carotenoids.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800171

7 January 2021

Identification, evolution, and essentiality of the mevalonate pathway for isopentenyl diphosphate biosynthesis in gram-positive cocci

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800171

7 January 2021

Sesquiterpene farnesol inhibits recycling of the C55 lipid carrier of the murein monomer precursor contributing to increased susceptibility to beta-lactams in methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800171

7 January 2021

Estimation of oral bioavailability of a long half-life drug in healthy subjects

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800171

7 January 2021

Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800171

7 January 2021

The FDA and the case of Ketek

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800171

7 January 2021

Identifiers

DOI

10.1002/CMDC.200800171

1 reference

22 December 2017

1 reference

22 December 2017